JP2003514935A5 - - Google Patents

Download PDF

Info

Publication number
JP2003514935A5
JP2003514935A5 JP2001538997A JP2001538997A JP2003514935A5 JP 2003514935 A5 JP2003514935 A5 JP 2003514935A5 JP 2001538997 A JP2001538997 A JP 2001538997A JP 2001538997 A JP2001538997 A JP 2001538997A JP 2003514935 A5 JP2003514935 A5 JP 2003514935A5
Authority
JP
Japan
Prior art keywords
polymer
diallylamine
poly
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001538997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514935A (ja
Filing date
Publication date
Priority claimed from GBGB9927088.6A external-priority patent/GB9927088D0/en
Application filed filed Critical
Publication of JP2003514935A publication Critical patent/JP2003514935A/ja
Publication of JP2003514935A5 publication Critical patent/JP2003514935A5/ja
Pending legal-status Critical Current

Links

JP2001538997A 1999-11-17 2000-11-10 ポリ(ジアリルアミン)ポリマー類の使用 Pending JP2003514935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9927088.6 1999-11-17
GBGB9927088.6A GB9927088D0 (en) 1999-11-17 1999-11-17 Use of poly(diallylamine) polymers
PCT/GB2000/004308 WO2001036510A2 (en) 1999-11-17 2000-11-10 Use of poly(diallylamine) polymers

Publications (2)

Publication Number Publication Date
JP2003514935A JP2003514935A (ja) 2003-04-22
JP2003514935A5 true JP2003514935A5 (https=) 2007-12-20

Family

ID=10864611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001538997A Pending JP2003514935A (ja) 1999-11-17 2000-11-10 ポリ(ジアリルアミン)ポリマー類の使用

Country Status (9)

Country Link
US (1) US7767229B1 (https=)
EP (1) EP1265942B1 (https=)
JP (1) JP2003514935A (https=)
AT (1) ATE287911T1 (https=)
AU (1) AU772653B2 (https=)
CA (1) CA2391539C (https=)
DE (1) DE60017805T2 (https=)
GB (1) GB9927088D0 (https=)
WO (1) WO2001036510A2 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606016D0 (en) * 2006-03-25 2006-05-03 Ionic Polymer Solutions Ltd Quaternary ammonium compounds and their uses
GB0613013D0 (en) 2006-06-30 2006-08-09 Novel Polymer Solutions Ltd Polymeric Materials and Methods for Manufacturing Them
DE102010002141A1 (de) 2010-02-19 2011-08-25 Momentive Performance Materials GmbH, 51373 Integrale Bestrahlungseinheit
JP5986081B2 (ja) 2010-08-02 2016-09-06 シンター ファイン ケミカルズ リミテッド 複合部材及びその製造方法
WO2012017235A1 (en) 2010-08-02 2012-02-09 Novel Polymer Solutions Limited Covered floors and methods of adhering flooring to a floor
WO2012017233A1 (en) 2010-08-02 2012-02-09 Novel Polymer Solutions Limited Methods of coating a low surface energy substrate
PL3400944T3 (pl) 2010-11-04 2020-11-16 Albireo Ab Inhibitory ibat w leczeniu chorób wątroby
GB201105453D0 (en) 2011-03-31 2011-05-18 Novel Polymer Solutions Ltd Window frames, structural elements for a roofed construction and methods of assembling same
JP6228918B2 (ja) 2011-08-18 2017-11-08 モーメンテイブ・パーフオーマンス・マテリアルズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 照射および成型ユニット
GB201115823D0 (en) 2011-09-13 2011-10-26 Novel Polymer Solutions Ltd Mineral processing
HK1210740A1 (en) 2012-06-11 2016-05-06 迈图高新材料集团 Method for producing plastic compound molded bodies
SI3287133T1 (sl) 2013-06-05 2019-09-30 Tricida Inc. Polimeri, ki vežejo protone,za peroralno dajanje
CA2952406A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for preventing or reducing coloration thereof
LT3229816T (lt) 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
WO2017193024A1 (en) 2016-05-06 2017-11-09 Tricida, Inc. Hcl-binding compositions for and method of treating acid-base disorders
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
ES2942443T3 (es) 2018-06-05 2023-06-01 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
BR112020024479A2 (pt) 2018-06-20 2021-03-02 Albireo Ab hidrato cristalino, modificações cristalinas de odevixibat, solvato misto de odevixibat, uso de modificação cristalina de odevixibat, processo para a preparação de modificação cristalina de odevixibat, e, composição farmacêutica
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
HUE060905T2 (hu) 2019-02-06 2023-04-28 Albireo Ab Benzotiadiazepin vegyületek és azok alkalmazása epesav modulátorként
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158184A1 (en) 2019-12-04 2021-08-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
ES2973549T3 (es) 2019-12-04 2024-06-20 Albireo Ab Compuestos de benzoti(di)azepina y su uso como moduladores de los ácidos biliares
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
EP4188541B1 (en) 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症(pfic)を処置するためのオデビキシバット
JP2024500309A (ja) 2020-12-04 2024-01-09 アルビレオ エービー ベンゾチア(ジ)アゼピン化合物および胆汁酸モジュレータとしてのその使用
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE520401A (https=) * 1952-06-03
US3957699A (en) * 1973-06-12 1976-05-18 Ici Australia Limited Process for polymerizing allylamines employing a redox initiator consisting of Fe++ or Ti+++ with H2 O2, hydroxyl amine, or hydroperoxides to form insoluble crosslinked polymers
US4121986A (en) * 1975-05-07 1978-10-24 Ici Australia Limited Process for the polymerization of polyallylamines in the presence of a mineral acid solution
JPS5747302A (en) * 1980-09-03 1982-03-18 Mitsubishi Petrochem Co Ltd Preparation of crosslinkable electrolytic polymer
JPS62257481A (ja) 1986-04-30 1987-11-10 三洋化成工業株式会社 染料固着剤
US4759923A (en) 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
JPH021358A (ja) * 1988-03-01 1990-01-05 Sanyo Chem Ind Ltd インクジェット記録紙用薬剤
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
SG105450A1 (en) * 1998-07-02 2004-08-27 Nat Starch Chem Invest Allylated amide compounds and die attach adhesives prepared therefrom
SG85658A1 (en) * 1998-07-02 2002-01-15 Nat Starch Chem Invest Package encapsulants prepared from allylated amide compounds
GB9816171D0 (en) * 1998-07-25 1998-09-23 Secr Defence Monomers and network polymers obtained therefrom
GB9816167D0 (en) * 1998-07-25 1998-09-23 Secr Defence Polymer production

Similar Documents

Publication Publication Date Title
JP2003514935A5 (https=)
US7767229B1 (en) Use of poly diallyamine polymers
Richmond et al. Preoperative morphine pre-empts postoperative pain
JP2004512318A5 (https=)
JP2004509061A5 (https=)
WO2001060381B1 (en) Nucleoside analogs with carboxamidine-modified bicyclic base
JP2023540149A (ja) 抗ウイルス化合物の製剤
JP2002525323A5 (https=)
KR19990087477A (ko) 완충된 오르쏘 에스테르 중합체를 포함하는 약학 조성물
RU2008139195A (ru) Замещенные арилсульфанамиды как противовирусные средства
CA2373833C (en) Medicinal compositions for preventing or treating viral myocarditis
CN111465392B (zh) 用于胍法辛透皮给药的含硅酮聚合物的透皮治疗系统
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
Heller et al. Development and applications of injectable poly (ortho esters) for pain control and periodontal treatment
JP2787539B2 (ja) ウイルス性疾患の予防または治療剤
FI4027973T3 (fi) Lääkkeensaattoformulaatioita
JP2002518506A5 (https=)
JP2005528332A5 (https=)
JPH1036365A5 (https=)
CN1179722A (zh) 用hiv蛋白酶抑制剂indinavir和逆转录酶抑制剂3tc,以及任选的azt、ddi或ddc,对hiv感染进行组合治疗
JP2004502696A5 (https=)
WO1998016252A1 (en) New pharmaceutical parenteral formulation of a thrombin inhibitor
JP2006083190A (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
AU2005244826B2 (en) Treatment or prevention of respiratory viral infections with immunomodulator compounds